| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer
|
Liu, Kang
|
|
|
7 |
3 |
p. 438-446
|
article
|
| 2 |
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
|
Takemura, Kosuke
|
|
|
7 |
3 |
p. 501-508
|
article
|
| 3 |
Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review
|
Khene, Zine-Eddine
|
|
|
7 |
3 |
p. 401-411
|
article
|
| 4 |
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study
|
Miyake, Hideaki
|
|
|
7 |
3 |
p. 625-632
|
article
|
| 5 |
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
|
Buteau, James P.
|
|
|
7 |
3 |
p. 544-552
|
article
|
| 6 |
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer
|
Li, Roger
|
|
|
7 |
3 |
p. 614-624
|
article
|
| 7 |
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
|
Myers, Amanda A.
|
|
|
7 |
3 |
p. 412-420
|
article
|
| 8 |
Contents
|
|
|
|
7 |
3 |
p. iii-x
|
article
|
| 9 |
Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis
|
Elst, Laura
|
|
|
7 |
3 |
p. 478-484
|
article
|
| 10 |
Cost Effectiveness of Magnetic Resonance Imaging Guidance Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy
|
Giuliani, Jacopo
|
|
|
7 |
3 |
p. 634-635
|
article
|
| 11 |
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort Study
|
Campi, Riccardo
|
|
|
7 |
3 |
p. 323-327
|
article
|
| 12 |
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
|
Bigot, Ludovic
|
|
|
7 |
3 |
p. 527-536
|
article
|
| 13 |
Digital Tracking of Patients Undergoing Radical Cystectomy for Bladder Cancer: Daily Step Counts Before and After Surgery Within the iROC Randomised Controlled Trial
|
Khetrapal, Pramit
|
|
|
7 |
3 |
p. 485-493
|
article
|
| 14 |
Editorial Board
|
|
|
|
7 |
3 |
p. i-ii
|
article
|
| 15 |
Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial
|
Van Blarigan, Erin L.
|
|
|
7 |
3 |
p. 519-526
|
article
|
| 16 |
Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma
|
Seelemeyer, Felix
|
|
|
7 |
3 |
p. 319-322
|
article
|
| 17 |
Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging–targeted Biopsy
|
Lenfant, Louis
|
|
|
7 |
3 |
p. 430-437
|
article
|
| 18 |
Local Therapy on Clinically Lymph Node–positive Prostate Cancer: A Systematic Review and Meta-analysis
|
Yaow, Clyve Yu Leon
|
|
|
7 |
3 |
p. 355-364
|
article
|
| 19 |
Magnetic Resonance Imaging–Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)
|
Klotz, Laurence
|
|
|
7 |
3 |
p. 456-461
|
article
|
| 20 |
Men’s Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy
|
Godtman, Rebecka Arnsrud
|
|
|
7 |
3 |
p. 553-562
|
article
|
| 21 |
Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis
|
Matsukawa, Akihiro
|
|
|
7 |
3 |
p. 376-400
|
article
|
| 22 |
On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on Immunotherapy
|
Saal, Jonas
|
|
|
7 |
3 |
p. 328-331
|
article
|
| 23 |
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study
|
Corsini, Christian
|
|
|
7 |
3 |
p. 605-613
|
article
|
| 24 |
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
|
Ost, Piet
|
|
|
7 |
3 |
p. 462-468
|
article
|
| 25 |
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate–Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study
|
Yu, Evan Y.
|
|
|
7 |
3 |
p. 509-518
|
article
|
| 26 |
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
|
Weickhardt, Andrew
|
|
|
7 |
3 |
p. 469-477
|
article
|
| 27 |
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis
|
Fazekas, Tamás
|
|
|
7 |
3 |
p. 365-375
|
article
|
| 28 |
Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study
|
Rosenvilde, Josephine Julie
|
|
|
7 |
3 |
p. 589-596
|
article
|
| 29 |
Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer
|
Schostak, Martin
|
|
|
7 |
3 |
p. 344-354
|
article
|
| 30 |
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office
|
Boormans, Joost L.
|
|
|
7 |
3 |
p. 537-543
|
article
|
| 31 |
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
|
Romero-Laorden, Nuria
|
|
|
7 |
3 |
p. 447-455
|
article
|
| 32 |
Real-life Perioperative Outcomes of Radical Prostatectomy using the French National Registry: A Plea for Promotion of Centralized Care and Access to Minimally Invasive Approaches
|
Baboudjian, Michael
|
|
|
7 |
3 |
p. 316-318
|
article
|
| 33 |
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
|
Sawaya, Ghady Bou-Nehme
|
|
|
7 |
3 |
p. 570-580
|
article
|
| 34 |
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
|
Kafka, Mona
|
|
|
7 |
3 |
p. 421-429
|
article
|
| 35 |
Re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010
|
Montorsi, Francesco
|
|
|
7 |
3 |
p. 636
|
article
|
| 36 |
Re: Hein V. Stroomberg, Signe Benzon Larsen, Torben Kjær Nielsen, J. Thomas Helgstrand, Klaus Brasso, Andreas Røder. Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.005
|
Gallo, Giacomo
|
|
|
7 |
3 |
p. 646-647
|
article
|
| 37 |
Re: Katharina Brück, Richard P. Meijer, Joost L. Boormans, et al. Disease-free Survival of Patients with Muscle-invasive Bladder Cancer Treated with Radical Cystectomy Versus Bladder-preserving Therapy: A Nationwide Study. Int J Radiat Oncol Biol Phys. In press. https://doi.org/10.1016/j.ijrobp.2023.07.027
|
Basile, Giuseppe
|
|
|
7 |
3 |
p. 637-638
|
article
|
| 38 |
Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.002
|
Ishiyama, Yudai
|
|
|
7 |
3 |
p. 642-643
|
article
|
| 39 |
Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006
|
Onal, Cem
|
|
|
7 |
3 |
p. 644-645
|
article
|
| 40 |
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508–15
|
D'Andrea, David
|
|
|
7 |
3 |
p. 639-640
|
article
|
| 41 |
Reply to Nikolaos Grivas, Christos Zampaftis, Dimitris Ermidis, Ioannis Leotsakos, Ioannis Katafigiotis, and Markos Karavitakis’s Letter to the Editor re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol 2023;6:399–405
|
Pasquier, David
|
|
|
7 |
3 |
p. 641
|
article
|
| 42 |
Re: Raghav Gupta, Adriana M. Pedraza, Michael A. Gorin, Ashutosh K. Tewari. Defining the Role of Large Language Models in Urologic Care and Research. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.017
|
Kleebayoon, Amnuay
|
|
|
7 |
3 |
p. 633
|
article
|
| 43 |
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
|
Le Guevelou, Jennifer
|
|
|
7 |
3 |
p. 332-343
|
article
|
| 44 |
Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and Protocol
|
Calleris, Giorgio
|
|
|
7 |
3 |
p. 494-500
|
article
|
| 45 |
The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality
|
Stone, Benjamin V.
|
|
|
7 |
3 |
p. 563-569
|
article
|
| 46 |
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study
|
Leung, David
|
|
|
7 |
3 |
p. 581-588
|
article
|
| 47 |
The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma?
|
Benjamin, David J.
|
|
|
7 |
3 |
p. 313-315
|
article
|
| 48 |
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients
|
Cussenot, Olivier
|
|
|
7 |
3 |
p. 597-604
|
article
|
Journal description